New Zealand markets open in 3 hours 28 minutes

Cortexyme, Inc. (CRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.68+0.12 (+1.14%)
At close: 04:00PM EST
10.51 -0.17 (-1.59%)
After hours: 07:57PM EST
Full screen
Trade prices are not sourced from all markets
Previous close10.56
Open10.18
Bid10.50 x 1100
Ask10.60 x 1100
Day's range10.15 - 10.87
52-week range10.15 - 121.98
Volume483,878
Avg. volume2,359,425
Market cap319.093M
Beta (5Y monthly)0.26
PE ratio (TTM)N/A
EPS (TTM)-2.94
Earnings date29 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est64.57
  • Motley Fool

    Why Cortexyme Stock Imploded in 2021

    The clinical-stage drugmaker's shares imploded last year in response to the failure of its lead Alzheimer's disease candidate atuzaginstat in a combined phase 2/3 study. Specifically, atuzaginstat reportedly missed both of its co-primary endpoints in the phase 2/3 Gain trial as a treatment for mild to moderate forms of Alzheimer's disease. Since announcing these disappointing trial results late last year, Cortexyme has said that it plans to trial the drug yet again.

  • Simply Wall St.

    Do Institutions Own Cortexyme, Inc. (NASDAQ:CRTX) Shares?

    If you want to know who really controls Cortexyme, Inc. ( NASDAQ:CRTX ), then you'll have to look at the makeup of its...

  • Motley Fool

    2 Short-Squeeze Candidates That Could Go Parabolic Soon

    Short squeezes can deliver enormous returns for investors in the blink of an eye. Several so-called "meme stocks" generated jaw-dropping gains for investors earlier this year due to this phenomenon. The mechanics of a short squeeze are fairly straightforward.